摘要:
An electrochemical treating device having low scale potential is disclosed. The device has a variety of configurations directed to the layering of the anionic exchange and cationic exchange. The treatment device can also comprise unevenly sized ion exchange resin beads and/or have at least one compartment that provides a dominating resistance that results in a uniform current distribution throughout the apparatus.
摘要:
Disclosed herein are novel compounds of Formula (I), wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases as well as proliferative disorders such as cancer.
摘要:
The invention provides a compound of Formula (I as defined herein, pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
摘要:
FIG. 1 is a perspective view of a watch band showing my new design; FIG. 2 is another perspective view thereof; FIG. 3 is a front elevational view thereof; FIG. 4 is a rear elevational view thereof; FIG. 5 is a left side elevational view thereof; FIG. 6 is a right side elevational view thereof; FIG. 7 is a top plan view thereof; FIG. 8 is a bottom plan view thereof; FIG. 9 is a perspective view of the watch band where the watch band is in a configuration of use; FIG. 10 is an enlarged view of portion 10 shown in FIG. 1; and, FIG. 11 is an enlarged view of portion 11 shown in FIG. 2. The dash-dash broken lines in the drawings depict portions of the watch band that form not part of the claimed design. The dot-dash broken lines of FIGS. 1, 2, 10 and 11 are included to show a partially enlarged view only and form no part of the claimed design.
摘要:
Method and system for electronically engaging customers for multiple business entities are disclosed. According to one embodiment, a CustomerOps platform is designed to provide customer operations to a plurality of computer applications (e.g. websites with multiple webpages, desktop programs and mobile applications) operated by respective businesses large or small. By providing a server or a cluster of servers, various activities by a user interacting with a designated computer application are captured and the data stream thereof is transported to a designated server. The stored data can be retrieved to assist the business of the designated computer application to engage the user contextually whenever there is a need. Such a CustomerOps platform facilitates efficient and more relevant human or automated assistance when the user desires to get engaged with the business that provides the designated computer application.
摘要:
The invention discloses a multi-metallic bulk catalyst with layered structure, wherein the metals in the multi-metallic bulk catalyst is consisted of a Group VIII metal MI, at least one metal MII with the valence of +3 and at least two Group VIB metals MIII+MIV, wherein (the mole number of MI+the mole number of MII):(the mole number of MIII+the mole number of MIV) is from 1:9 to 9:1; the mole number of MI:the mole number of MII is from 1:5 to 5:1; and the mole number of MIII:the mole number of MIV is from 1:5 to 5:1. The invention also discloses the preparation method and use of the above catalyst. The invention is use for the hydrodesulfurization of diesel distillate including 4,6-dimethyldibenzothiophene, wherein the catalyst exhibits a extreme high hydrodesulfurization activity. Thus, the ultra-deep hydrodesulfurization is achieved and the cost of the bulk catalyst is reduced.
摘要:
A mobility management node and a method in a mobility management node for reducing signalling caused by changes of location of a radio terminal, which mobility management node is configured to be operatively comprised by a wireless communication system and to operatively manage the mobility of the radio terminal and to operatively communicate with a gateway node acting as an interface between the system and an external network. The method comprises obtaining initial position information; obtaining boundary information indicating a boundary area wherein at least one of a policy or a charging rule is to be applied for the radio terminal; obtaining current position information; determining whether the radio terminal is inside or outside the boundary area; providing mobility information when the radio terminal is outside the boundary area and not providing mobility information to the gateway node when the radio terminal is inside the boundary area.
摘要:
The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts, wherein A, R1, R2, R3 and m, are defined in the description. The present invention relates also to methods of making said compounds, and compositions containing said compounds which are useful for inhibiting kinases such as Glycogen Synthase kinase 3 (GSK-3), Rho kinase (ROCK), Janus Kinases (JAK), Cdc7, AKT, PAK4, PLK, CK2, KDR, MK2, JNK1, aurora, pim 1 and nek 2.
摘要:
Embodiments of apparatuses, systems, and methods for a temporal hole filling are described. Specifically, an embodiment of the present invention may include a depth-based hole filling process that includes a background modeling technique (SGM). Beneficially, in such an embodiment, holes in the synthesized view may be filled effectively and efficiently.
摘要:
Nuclear receptor LXR is an important member of 49 nuclear receptors in human bodies and has irreplaceable regulatory effects on cholesterol and fat metabolisms. The regulation of the biological activity of LXR may have therapeutic effects to the conditions such as cardiovascular and cerebrovascular obstructions, non-insulin dependent hyperglycemia, immune function disorders, and central nerve functional degeneration. We have developed a group of novel Chinese materia medica preparations targeting nuclear receptor LXR by using a computer-simulated docking technology and a process for determining biological activities of human cells cultured ex vivo. The group of preparations are featured by simple ingredients, low costs, easy to prepare, etc. No significant adverse effects were found in initial acute toxicology analysis which was carried out using mice.